Six-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing.

Source:http://linkedlifedata.com/resource/pubmed/id/16770257

Download in:

View as

General Info

PMID
16770257